Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
Journal: Nature Biotechnology
Published: 2020-01-13
DOI: 10.1038/s41587-019-0390-x
Affiliations: 12
Go to article